In focus · trending topic

SunGen Pharma

18 stories · following the connections

Elite Pharmaceuticals and SunGen Pharma File ANDA

By Nasdaq OMXFeb 8, 2018, 4:32 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

By Nasdaq OMXJan 10, 2018, 1:02 PM UTC

Elite Announces Co-Development of Four Additional Products with SunGen Pharma

By Nasdaq OMXJul 28, 2017, 12:00 PM UTC

Elite Announces New Development and License Agreement with SunGen Pharma LLC

By Nasdaq OMXJul 12, 2017, 12:32 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:57 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC